Endodiabesity

The North West of England Endocrinology, Diabetes and Obesity Newsletter

15th Northwest Diabetes, Endocrinology and Cardiovascular Update: 8 Dec 2018

Posted by Guest Author on 1 November, 2018

What: 15th Northwest Diabetes, Endocrinology and Cardiovascular Update

When: Saturday, 8th Dec 2018

Where: Pendulum Hotel and Manchester Conference Centre, Weston Building, Sackville Street, Manchester, M1 3BB                                                                                                   http://www.manchesterconferencecentre.co.uk

The nearest carpark is situated on Charles street http://www.estates.manchester.ac.uk/services/operationalservices/carparking

To register, please complete the registration form on the following website:

https://www.surveymonkey.co.uk/r/CHH6JS5

For queries: northwest.cpd@gmail.com

Applied for 5 CPD points

Organised by Dr Handrean Soran and Dr Naveed Younis

The sponsors have had no involvement in developing the content of the meeting.

The meeting is free for Health Care professionals, scientists and students.

Limited places available, please book your place as soon as possible.

Provisional Programme

0830–0900 Registration & coffee
0855 Welcome Dr Handrean Soran
  First session
0900–0945 Managing hypertension for general practitioners and physicians

i.        When to treat?

ii.        How to treat?

iii.        What treatment target?

iv.        Should we manage hypertension in patients with diabetes differently?

v.        When to refer to secondary care?

Professor Anthony Heagerty,

University of Manchester, UK

0945-1030 Chronic kidney disease

i.        The impact of chronic kidney disease

ii.        Initial assessment of CKD in primary care

iii.        When to refer patients with CKD to secondary care

iv.        Diabetes nephropathy

When to think beyond diabetes nephropathy?

Initial assessment in primary care

Should we combine ACEIs and ARBs?

Professor Philip Kalra,

Salford Royal NHS Foundation Trust

1030-1115 An update on management of hyperlipidaemia

i.        What is new with LDL cholesterol lowering: PCSK9 monoclonal antibodies

ii.        Hypertriglyceridaemia: how to manage and what is new?

iii.        Diabetes Dyslipidaemia

iv.        Statin intolerance

Dr Handrean Soran,

Manchester University NHS Foundation Trust

1115-1135 Moderated Panel discussion
1135–1215 Sandwich lunch & networking
  Second session
1215-1300 Making sense of clinical guidelines for diabetes in a world of obesity

i.        Treatment options

ii.        Managing diabesity

iii.        When to consider metabolic surgery

Dr Akheel Syed,

Salford Royal NHS Foundation Trust

1300-1345 Managing cardiovascular risk in patients with diabetes: Is there a role for glucose lowering agents?

 

Dr Naveed Younis,

Manchester University NHS Foundation Trust

1345-1400 Nutraceuticals in clinical practice and recent advances TBC
1410-1430  Moderated panel discussion
1430 End
   

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s